MP-1032 (MetrioPharm)

N/A

Report date: 2025/01/26 17:18:35
NME

Base Information

Drug NameMP-1032 (MetrioPharm)
Drug Alias NameMP-1032 (MetrioPharm)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase stimulants
TargetsSuperoxide dismutase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetriopharm Ag
China Registration ClassN/A

Develop Information

Active CompaniesMetriopharm Ag
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A